Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03683680
NA
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Sponsor: Dana-Farber Cancer Institute
View on ClinicalTrials.gov
Summary
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2018-10-31
Completion Date
2030-10-01
Last Updated
2025-12-11
Healthy Volunteers
No
Conditions
Interventions
OTHER
MPT Test
molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms
OTHER
CLDN15/VIM Test
molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States